TSUGAMI CHINA (01651) spent HK$1.802 million on March 4 to repurchase 100,000 shares.

04/03/2025

GMT Eight

TSUGAMI CHINA (01651) announced on March 4, 2025 that the company will spend 1.802 million Hong Kong dollars to repurchase 100,000 shares at a repurchase price of 17.94-18.04 Hong Kong dollars per share.

Chongqing Pharscin Pharmaceutical (002907.SZ) obtained a special medical purpose formula food production license.

Zhejiang Wolwo Bio-Pharmaceutical (300357.SZ): Eczema diagnostic patch 02 drug clinical trial application accepted.

Contact: contact@gmteight.com

TSUGAMI CHINA (01651) spent HK$1.802 million on March 4 to repurchase 100,000 shares.

RECOMMEND

US Stock Market Move | Daqo New Energy Corp Sponsored ADR (DQ.US) rose more than 9%, with a total market value of nearly $1.35 billion.

US Stock Market Move | Bitcoin concept stocks fell, Strategy(MSTR.US) dropped more than 4.6%

US Stock Market Move | ZAI LAB (ZLAB.US) rises more than 5%. New drug repotrectinib approved for listing in Taiwan region.